Carve out

Sale of a portfolio of poultry vaccines for the Mexican market to Lapisa

October 2017: Capitalmind advised Boehringer Ingelheim on the carve-out of Gallimune 302 and Volvac, a portfolio of poultry vaccines for the Mexican market, and the subsequent sale to Lapisa

read more

Sale of Previcox South Korea, a Boehringer Ingelheim product, to Green Cross Veterinary Products

October 2017: Capitalmind advised Boehringer Ingelheim on the carve-out of Previcox, an animal health product for the South Korean market, and the subsequent sale to Green Cross Veterinary Products

read more

BeOne Invest BV acquired b1 Engineering Solutions by way of carve out from Blaupunkt Group

March 2016: Capitalmind advised BeOne Invest BV on the acquisition of b1 Engineering Solutions by way of carve out from Blaupunkt Group

read more

Air Liquide sold German subsidiary to its management

September 2014: Capitalmind advised Air Liquide on the carve out of its German subsidiary Cryotherm to its management

read more

Sale of Sogeval’s biosecurity business to Theseo

June 2014: Capitalmind advised Sogeval on the disposal of its biosecurity business to Theseo (Sofiproteol)

read more
Page 1 of 512345